Mechanisms at the interface of DNA damage repair and transcription

Projektinformationen

STOP-FIX-GO

ID Finanzhilfevereinbarung: 101043815

DOI

10.3030/101043815

EK-Unterschriftsdatum 23 Mai 2022

Startdatum 1 Juni 2022

Enddatum 31 Mai 2027

Finanziert unter

• European Research Council (ERC)

Gesamtkosten

€ 1 999 764,00

EU-Beitrag

€ 1 999 764,00

Koordiniert durch

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

Periodic Reporting for period 1 - STOP-FIX-GO (Mechanisms at the interface of DNA damage repair and transcription)

Berichtszeitraum: 2022-06-01 bis 2024-11-30

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

Bulky DNA lesions are a major obstacle during gene transcription by RNA polymerase II enzymes (RNAPII). The stalling of RNAPII at DNA lesions triggers a genome-wide transcriptional arrest. Transcription-coupled repair (TCR) is a specialized DNA repair pathway that selectively removes DNA lesions from actively transcribed genes to restore transcription. Stalled RNAPII at DNA lesions forms a roadblock for advancing DNA replication forks resulting in toxic collisions. The mechanisms that enable the repair of transcription-blocking DNA lesions, the restoration of transcription after repair and the resolution of transcription-replication conflicts are poorly understood. To address these knowledge gaps, I propose to establish a series of innovative approaches aimed at identifying the mechanisms involved in the cellular responses to transcription-blocking DNA damage. We will focus on the functional characterization of known and several promising new TCR factors that we recently identified in combined genome-wide CRISPR and targeted proteomics screens.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

During transcription-coupled DNA repair (TCR), RNA polymerase II (Pol II) transitions from a transcriptionally active to an arrested state that allows for removal of DNA lesions. This transition requires site-specific ubiquitylation of Pol II by the CRL4CSA ubiquitin ligase, a process that is facilitated by ELOF1 in an unknown way. Using cryo-EM, biochemical assays, and cell biology approaches, we show that ELOF1 serves as an adaptor to stably position UVSSA and the CSA ubiquitin ligase on arrested RNAPII, leading to ligase neddylation and activation of RNAPII ubiquitylation. In the presence of ELOF1, a TFIIS-like element in UVSSA gets ordered and extends through the RNAPII pore, thus preventing reactivation of Pol II by TFIIS. Our results provide the structural basis for RNAPII ubiquitylation and inactivation in transcription-coupled repair. Recent studies have outlined the stepwise assembly of TCR factors CSB, CSA, UVSSA, and TFIIH around lesion-stalled RNAPII. However, the mechanism and factors required for the transition to downstream repair steps, including RNAPII removal to provide repair proteins access to the DNA lesion, remain unclear. Here, we identify STK19 as a TCR factor facilitating this transition. Loss of STK19 does not impact initial TCR complex assembly or RNAPII ubiquitylation but delays lesion-stalled RNAPII clearance, thereby interfering with the downstream repair reaction. Cryo-EM and mutational analysis reveal that STK19 associates with the TCR complex, positioning itself between RNAPII, UVSSA, and CSA. The structural insights and molecular modeling suggest that STK19 positions the ATPase subunits of TFIIH onto DNA in front of RNAPII. Together, these findings provide new insights into the factors and mechanisms required for TCR.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

This ERC project will break new grounds by offering a detailed understanding of the mechanisms that enable cells to overcome transcriptional roadblocks.